Labetalol Hydrochloride Injection, USP

5 mg/mL

100 mg/20 mL

Multiple Dose Glass Fliptop Vial

Unit of Sale NDC: 00409-2267-20

Depleted
To set product alerts you must or register

Cap color: Mist Gray

Wholesalers
Cardinal 2927671
Cencora 10002121
McKesson 1225259
Morris & Dickson 335075
Ordering information
Unit of Sale size 1 Vial
Case size 50 x 1
Cases per tier 10
Cases per pallet 90
Allergy information
Non-DEHP
Latex information
Availability specifics
Additional information View

If Latex Information is present above, then natural rubber latex has not been used in the manufacturing of this device or drug container closure system.

If Preservative Free is present above, then this product does not contain ingredients identified as a preservative, as defined by the USP.

Cap color: Mist Gray

Unit of Sale NDC:00409-2267-20

Labetalol Hydrochloride Injection, USP

Unit of Use NDC:00409-2267-20

Labetalol Hydrochloride Injection, USP

Related news

Product Updates

Product NDC Change: Fluconazole in Sodium Chloride Injection, USP 400 mg/200 mL (2 mg/mL) Flexible Container

Product Updates

Product NDC Change: Fluconazole in Sodium Chloride Injection, USP 200 mg/100 mL (2 mg/mL) Flexible Container

Product Updates

Product NDC and Pack Size Change: Marcaine® 0.5% (bupivacaine hydrochloride injection, USP) 50 mg/10 mL (5 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC Change: Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC Change: Midazolam Injection, USP CIV 2 mg/2 mL (1 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change for Metoclopramide Injection, USP 10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change for Camptosar® (Irinotecan Hydrochloride Injection, USP) 300 mg/15 mL (20 mg/mL) Single Dose Vial

Product Updates

NDC and Formulation Change for Levofloxacin in 5% Dextrose Injection Flexible Container Presentations

Recalls Withdrawals or Important Safety Information

Urgent: Drug Recall

Product Updates

NDC Change for Idamycin PFS® (idarubicin hydrochloride injection), 10 mg/10 mL (1 mg/mL) Single Dose Vial

Product Updates

NDC Change for Idamycin PFS® (idarubicin hydrochloride injection), 20 mg/20 mL

Product Updates

Pfizer Hospital NDC and Packaging Change: Precedex

Product Updates

Pfizer Hospital NDC and Labeling Change: Morphine

Product Updates

NDC and Packaging Change for Labetalol Hydrochloride Injection, USP 100 mg/20 mL (5 mg/mL) Multiple-dose Vial

Product Updates

NDC and Labeling Change: Rocuronium Bromide NDC Labeling Change

Product Updates

NDC and Labeling Change Linezolid Injection in 0.9% Sodium Chloride 600 mg/300 mL (2 mg/mL) Single-dose Container

Product Updates

NDC and Labeling Change: Ciprofloxacin in 5% Dextrose Injection, USP 200 mg/100 mL (2 mg/mL) Single-Dose Flexible Container

Product Updates

NDC and Labeling Change for Magnesium Sulfate in Water for Injection 40 g/1000 mL (40 mg/mL) Single-Dose Flexible Container

Product Updates

Product NDC Change for Ciprofloxacin in 5% Dextrose Injection, USP 400 mg/200 mL (2 mg/mL) Single Dose Flexible Container

Product Updates

NDC and Packaging Update for Heparin Sodium in Sodium Chloride Injection Flexible Container, Multiple Presentations

Product Updates

NDC and Packaging Change for Heparin Sodium in 0.45% Sodium Chloride Injection, 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container

Product Updates

NDC and Packaging Update for Magnesium Sulfate in Water for Injection Flexible Container, Multiple Presentations

Product Updates

NDC and Packaging Change for Heparin Sodium in 0.45% Sodium Chloride Injection, 25,000 USP Units/500 mL (50 USP Units/mL) Flexible Container

Product Updates

NDC and Packaging Change for Heparin Sodium in 5% Dextrose Injection 25,000 USP Units/250 mL (100 USP Units/mL) Flexible Container